Tweedy, Browne Co’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-339,637
Closed -$8.13M 49
2023
Q2
$8.13M Sell
339,637
-3,922
-1% -$89.9K 0.43% 29
2023
Q1
$7.3M Buy
343,559
+4,647
+1% +$89K 0.4% 30
2022
Q4
$5.54M Sell
338,912
-664,124
-66% -$9.85M 0.29% 32
2022
Q3
$14.1M Sell
1,003,036
-13,404
-1% -$253K 0.62% 26
2022
Q2
$25.4M Sell
1,016,440
-10,495
-1% -$314K 1.04% 23
2022
Q1
$34.6M Buy
1,026,935
+990
+0.1% +$32.6K 1.12% 22
2021
Q4
$33.3M Buy
1,025,945
+176,223
+21% +$5.8M 1.06% 23
2021
Q3
$29.7M Buy
849,722
+244,758
+40% +$9.56M 0.99% 24
2021
Q2
$25.1M Buy
604,964
+74,900
+14% +$2.99M 0.71% 29
2021
Q1
$19.5M Buy
+530,064
New +$20M 0.57% 29

Other funds holding FMS

Tweedy, Browne Co's FMS Position: Q3 2023 in Review

Tweedy, Browne Co sold out of Fresenius Medical Care (FMS) in Q3 2023, closing a stake of 339,637 shares — an estimated $8.13M sold.

Tweedy, Browne Co first reported a position in FMS in Q1 2021 and held it in 10 quarters. The position peaked at $34.6M in Q1 2022. 148 funds tracked by Wall St. Rank hold FMS as of Q3 2023.

  • Tweedy, Browne Co reported no remaining Fresenius Medical Care position as of Q3 2023 after selling out during the quarter.
  • Tweedy, Browne Co sold 339,637 Fresenius Medical Care shares in Q3 2023, an estimated $8.13M.
  • Tweedy, Browne Co first reported a position in Fresenius Medical Care in Q1 2021 and held it in 10 quarters.
  • Tweedy, Browne Co's Fresenius Medical Care position peaked at $34.6M in Q1 2022.
  • 148 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2023.

Based on Tweedy, Browne Co's 13F filing for Q3 2023, filed 13 Nov 2023.